Meena Thayu - Janssen Pharmaceuticals

基本信息

浏览量：64

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 76 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Brief Report on Stable Disease among Amivantamab-treated Patients with Post-platinum Epidermal Growth Factor Receptor Exon 20 Insertion–Mutated Non-small Cell Lung Cancer: A Response-based Analysis from the CHRYSALIS Study

Nicolas Girard,Keunchil Park,Se-Hoon Lee,Santiago Viteri,Claudio A. Schioppa,Joris Diels, Mustafa Oguz, Bernardo H. Rodrigues,Nora Rahhali,Jan Sermon,Francesca Ghilotti,Tracy Li,Meena Thayu,Roland E. Knoblauch,Parthiv Mahadevia,Byoung Chul Cho

CANCER TREATMENT AND RESEARCH COMMUNICATIONS (2024)

引用0浏览0WOS引用

Abstract CT054: Amivantamab in Wild-Type Advanced Non-Small Cell Lung Cancer after Disease Progression on Checkpoint Inhibition and Chemotherapy: Results from the Phase 1b CHRYSALIS Study

Byoung Chul Cho,Jonathan Goldman,Natasha Leighl,Filippo De Braud,Ki Hyeong Lee,François Ghiringhelli,Pilar Garrido,Julio Peguero,Benjamin Besse,Philippe Cassier,Nicolas Girard,Maria de Miguel,Rosa Alvarez, Alastair Greystroke,Yuichiro Ohe,Te-Chun Hsia,Joshua C. Curtin, Sanjib Chowdhury,Xuesong Lyu,Grace Gao, Siyang Qu,Patricia Lorenzini, Aastha Kapoor, Priya Kim,Mahadi Baig,Meena Thayu,Roland E. Knoblauch,Sandrine Hiret,Pascale Tomasini

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Amivantamab Monotherapy in Relapsed/refractory Metastatic Colorectal Cancer: OrigAMI-1, an Open-Label, Phase 1b/2 Study

Paul Eliezer Oberstein,Victor Moreno,Kanwal Pratap Singh Raghav,Yong Sang Hong,Sae-Won Han,Yu-Li Su,Ying Yuan,Filippo Pietrantonio,Eric Van Cutsem,Cathy Eng,Joshua C. Curtin, Sanjib Chowdhury, Rianka Bhattacharya,Raymond Scott Maul,Ryota Iwasawa,Robert W. Schnepp,Roland Elmar Knoblauch,Meena Thayu,Gwo Fuang Ho,Han Sang Kim

Journal of Clinical Oncologyno. 3_suppl (2024): 135-135

引用0浏览0引用

Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2

S. -H. Lee,B. C. Cho,A. I. Spira,S. -H. I. Ou,S. N. Waqar, S. Shah,L. Trani, P. -L. Chu,M. Thayu,R. E. Knoblauch,J. M. Bauml,M. E. Marmarelis

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S146-S147

引用0浏览0引用

30 Long-term Efficacy, Safety, and Predictors of Response to Amivantamab among Patients with Post-Platinum EGFR Ex20ins-mutated Advanced NSCLC

P. Garrido Lopez,N. Girard,B. C. Cho,J. Sabari,A. Spira,R. E. Sanborn,K. Goto,J. C-H. Yang,J. Curtin,X. Lyu, A. He,J. Penton, J. Edwards, G. Low Massin,K. Xia,M. Chioda,M. Thayu,R. E. Knoblauch,P. Mahadevia,N. Leighl

JOURNAL OF THORACIC ONCOLOGYno. 4 (2023): S36-S37

引用0浏览0引用

Amivantamab and Lazertinib in Treatment-Naïve EGFR-mutated Advanced Non–small-Cell Lung Cancer (NSCLC): Long-term Follow-Up and Ctdna Results from CHRYSALIS

Se-Hoon Lee,Byoung Chul Cho,Ji-Youn Han,Eun Kyung Cho,Jong-Seok Lee,Ki Hyeong Lee,Joshua C. Curtin,Grace Gao,John Xie,Robert W. Schnepp,Joshua Michael Bauml,Roland E. Knoblauch,Meena Thayu,Dong-Wan Kim

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用1浏览0引用

A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy or in Combination with Standard-of-care Chemotherapy in Participants with Advanced or Metastatic Colorectal Cancer

Paul Eliezer Oberstein,Cathy Eng,Eric Van Cutsem,Elena Elez,Michel Ducreux, Sejal Patel, Dona Pang, Leann Milford,Ryota Iwasawa,Robert W. Schnepp,Roland Knoblauch,Meena Thayu

Journal of Clinical Oncologyno. 4_suppl (2023): TPS279-TPS279

引用0浏览0引用

Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non-Small Cell Lung Cancer

Nahor Haddish-Berhane,Yaming Su,Alberto Russu,Meena Thayu,Roland E. Knoblauch,Jaydeep Mehta,John Xie, Eric Gibbs,Yu-Nien Sun,Honghui Zhou

Clinical Pharmacology & Therapeuticsno. 3 (2023): 468-477

引用3浏览0WOS引用

Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study

JOURNAL OF THORACIC ONCOLOGYno. 11 (2023): S93-S94

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn